Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Shin Maeda, Haruki Uojima et al.|Hepatology Research|2021Cited by 50
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinomaMakoto Chuma, Shin Maeda, Takashi Kumada et al.|Hepatology International|2024Cited by 11
Contents Vol. 82, 2010Gian Eugenio Tontini, Alban Denys, Anna Maria Polifemo et al.|Digestion|2010Cited by 0
Author Index Vol. 82, 2010Gian Eugenio Tontini, Alban Denys, Emanuele Rondonotti et al.|Digestion|2010Cited by 0